Filsuvez in Moderate-to-Severe Epidermolysis Bullosa Simplex

Clinical trial NCT07756138 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07756138
Sponsor: Stanford University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Epidermolysis Bullosa Simplex

Start date: 2026-10-01
Primary completion: 2027-07-02
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.